H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases

Respiratory diseases represent a significant public health challenge, in terms of disability and premature mortality, and also direct healthcare costs, drugs prescribed and the indirect costs related to lost productivity [1]. This European Lung Corner article summarises five key messages for future research and practice in preventing and treating lung diseases based on outcomes and perspectives from five Horizon 2020 projects http://bit.ly/2YCJV5N

[1]  Charlotte C Poot,et al.  COPD’s early origins in low-and-middle income countries: what are the implications of a false start? , 2019, npj Primary Care Respiratory Medicine.

[2]  N. Chavannes,et al.  High COPD prevalence at high altitude: does household air pollution play a role? , 2019, European Respiratory Journal.

[3]  E. Fernández,et al.  Quitting activity and use of cessation assistance reported by smokers in eight European countries: Findings from the EUREST-PLUS ITC Europe Surveys , 2018, Tobacco induced diseases.

[4]  G. Joos,et al.  The European Respiratory Society's 10 Principles for Lung Health , 2018, European Respiratory Journal.

[5]  P. Bamidis,et al.  Using the Social-Local-Mobile App for Smoking Cessation in the SmokeFreeBrain Project: Protocol for a Randomized Controlled Trial , 2018, JMIR research protocols.

[6]  E. Fernández,et al.  Study Protocol of European Regulatory Science on Tobacco (EUREST-PLUS): Policy implementation to reduce lung disease , 2018, Tobacco induced diseases.

[7]  P. Bamidis,et al.  Exploring the Neuroplastic Effects of Biofeedback Training on Smokers , 2018, Behavioural neurology.

[8]  A. Sheikh,et al.  The safety, effectiveness and cost‐effectiveness of cytisine in achieving six‐month continuous smoking abstinence in tuberculosis patients—protocol for a double‐blind, placebo‐controlled randomized trial , 2018, Addiction.

[9]  T. Sooronbaev,et al.  Author Correction: Recurrent lower respiratory illnesses among young children in rural Kyrgyzstan: overuse of antibiotics and possible under-diagnosis of asthma. A qualitative FRESH AIR study , 2018, npj Primary Care Respiratory Medicine.

[10]  A. Sheikh,et al.  Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness–implementation study , 2018, BMJ Open.

[11]  S. Gallus,et al.  Passive exposure to electronic cigarette aerosol in Italy: data from the TackSHS pan-European survey , 2018, Tobacco Prevention & Cessation.

[12]  E. Fernández,et al.  Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014 , 2018, Tobacco Control.

[13]  C. Vardavas,et al.  Plain packaging of tobacco products in the European Union: an EU success story? , 2017, European Respiratory Journal.

[14]  Fabio Babiloni,et al.  Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements , 2017, Journal of visualized experiments : JoVE.

[15]  E. Fernández,et al.  The TackSHS Project. Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations , 2017 .

[16]  C. Gorre.  Global Alliance for Chronic Diseases , 2017 .

[17]  E. Fernández,et al.  Secondhand smoke risk perception and smoke-free rules in homes: a cross-sectional study in Barcelona (Spain) , 2017, BMJ Open.

[18]  E. Fernández,et al.  Voluntary home smoking ban: prevalence, trend and determinants in Italy. , 2016, European journal of public health.

[19]  N. Chavannes,et al.  FRESH AIR: an implementation research project funded through Horizon 2020 exploring the prevention, diagnosis and treatment of chronic respiratory diseases in low-resource settings , 2016, npj Primary Care Respiratory Medicine.

[20]  C. Vardavas.  EUREST PLUS - European Regulatory Science on Tobacco: Policy implementation to reduce lung diseases - Proposal (Horizon2020) , 2016 .

[21]  Lara Passante,et al.  Chronic respiratory diseases and lung cancer research: a perspective from the European Union , 2015, European Respiratory Journal.

[22]  R. Loddenkemper,et al.  Respiratory health and disease in Europe: the new European Lung White Book , 2013, European Respiratory Journal.

[23]  T. Lancet.  The Global Alliance for Chronic Diseases , 2009, The Lancet.

[24]  J Bousquet,et al.  Global Alliance against Chronic Respiratory Diseases , 2007, European Respiratory Journal.

[25]  J. Buzek.  European Regulatory Science on Tobacco: Policy implementation to reduce lung diseases (EUREST-PLUS) , 2019 .